DWTX
Dogwood Therapeutics, Inc.
Company overview
- Market capitalization
- $46.23M
- Employees
- 8
- Latest publication
- 2026-09-29
About Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended to synergistically suppress herpesvirus activation; and Serpin Peptide 16 that is in early Phase 1 development to reduce neuropathy secondary to treat chemotherapeutic agents that are neurotoxic. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is based in Alpharetta, Georgia.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 3,246,519USD | 2,669,779USD | 2,337,788USD | 14,521,342USD | 2,569,943USD | 2,436,998USD | 2,315,949USD | 535,162USD |
| Total Operating Expenses | 14,063,525USD | 5,076,366USD | 3,806,279USD | 15,809,125USD | 3,923,115USD | 4,429,926USD | 7,542,151USD | 2,301,172USD |
| Net Income | -11,529,609USD | -4,986,614USD | -3,780,449USD | -15,744,616USD | -3,807,353USD | -10,924,952USD | -7,727,872USD | -2,280,684USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Selling General Administrative | — | 2,406,587USD | 1,468,491USD | 1,287,783USD | 1,353,172USD | 1,992,928USD | 5,226,202USD | 1,766,010USD |
| Operating Income | — | -5,076,366USD | -3,806,279USD | -15,809,125USD | -3,923,115USD | -4,429,926USD | -7,542,151USD | -2,301,172USD |
| Net Interest Income | — | 77,350USD | 52,067USD | 80,582USD | 111,379USD | -147,090USD | -155,437USD | 20,488USD |
| Income Before Tax | — | -4,985,421USD | -3,748,608USD | -15,746,052USD | -3,807,204USD | -10,734,410USD | -7,728,375USD | -2,280,684USD |
| Income Tax Expense | — | -1,193USD | 31,841USD | -1,436USD | 149USD | 190,542USD | -503USD | — |
| Tax Provision | — | 1,193USD | 31,841USD | -1,436USD | 149USD | 190,542USD | -503USD | 0USD |
| Net Income From Continuing Ops | — | -4,986,614USD | -3,780,449USD | -15,744,616USD | -3,807,353USD | -10,924,952USD | -7,727,872USD | -2,280,684USD |
| Ebitda | — | -5,076,366USD | -3,806,279USD | -15,728,796USD | -3,905,859USD | -4,412,904USD | -7,572,938USD | -2,301,172USD |
| Reconciled Depreciation | — | 0USD | 0USD | -32,215USD | 17,256USD | 17,022USD | — | 0USD |
| Total Other Income Expense Net | — | 90,945USD | 57,671USD | 63,073USD | 115,911USD | -6,304,484USD | -186,224USD | 20,488USD |
| Ebit | — | — | — | -15,746,052USD | -3,923,115USD | -4,429,926USD | -7,542,151USD | -2,301,172USD |
| Depreciation And Amortization | — | — | — | 17,256USD | 17,256USD | 17,022USD | — | — |
| Cost Of Revenue | — | — | — | — | 17,256USD | 17,022USD | 12,177USD | — |
| Gross Profit | — | — | — | — | -17,256USD | -17,022USD | -12,177USD | — |
| Interest Expense | — | — | — | — | — | 147,090USD | 155,437USD | — |
| Interest Income | — | — | — | — | — | — | — | 20,488USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — | — |
| Research Development | 21,866,071USD | 3,530,913USD | 1,728,078USD | 8,069,628USD | 10,795,688USD | 194,013USD | 800,620USD | 854,109USD |
| Selling General Administrative | 6,102,374USD | 8,696,335USD | 3,718,841USD | 4,245,681USD | 4,845,252USD | 9,811,381USD | 1,377,879USD | 1,107,386USD |
| Total Operating Expenses | 27,968,445USD | 12,227,248USD | 5,446,919USD | 12,315,309USD | 15,640,940USD | 10,005,394USD | 2,178,499USD | 1,961,495USD |
| Operating Income | -27,968,445USD | -12,227,248USD | -5,446,919USD | -12,315,309USD | -15,640,940USD | -10,005,394USD | -2,178,499USD | -1,961,495USD |
| Net Interest Income | 96,938USD | -92,192USD | 150,904USD | 67,475USD | 5,672USD | -384,222USD | — | — |
| Income Before Tax | -34,036,274USD | -12,350,227USD | -5,296,015USD | -12,247,834USD | -15,960,268USD | -10,346,395USD | -2,473,627USD | -2,113,592USD |
| Income Tax Expense | 221,096USD | -503USD | — | — | — | — | — | — |
| Tax Provision | 221,096USD | -503USD | 0USD | 0USD | 0USD | 0USD | — | — |
| Net Income | -34,257,370USD | -12,349,724USD | -5,296,015USD | -12,247,834USD | -15,960,268USD | -10,346,395USD | -2,473,627USD | -2,113,592USD |
| Net Income From Continuing Ops | -34,257,370USD | -12,349,724USD | -5,296,015USD | -12,247,834USD | -15,960,268USD | -10,346,395USD | — | — |
| Ebit | -27,968,445USD | -12,258,035USD | -5,446,919USD | -12,315,309USD | -15,640,940USD | -10,005,394USD | -2,178,499USD | -1,961,495USD |
| Ebitda | -27,966,382USD | -12,245,858USD | -5,446,919USD | -12,315,309USD | -15,640,940USD | -10,005,394USD | -2,178,499USD | -1,961,489USD |
| Depreciation And Amortization | 2,063USD | 12,177USD | — | — | — | — | — | — |
| Reconciled Depreciation | 2,063USD | 12,177USD | 0USD | — | — | — | — | — |
| Total Other Income Expense Net | -6,067,829USD | -122,979USD | 150,904USD | 67,475USD | -319,328USD | -341,000USD | -295,128USD | -152,097USD |
| Cost Of Revenue | — | 12,177USD | — | — | — | — | — | — |
| Gross Profit | — | -12,177USD | — | — | — | — | — | — |
| Interest Expense | — | 92,192USD | — | — | — | 384,222USD | 295,128USD | 152,103USD |
| Interest Income | — | — | 150,904USD | 67,475USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 80,495,480USD | 95,207,871USD | 90,171,237USD | 91,992,613USD | 96,692,527USD | 96,984,688USD | 94,308,246USD | 2,283,249USD |
| Cash And Equivalents | 9,610,033USD | — | — | — | — | — | — | — |
| Total Current Assets | 11,025,905USD | 15,004,138USD | 8,431,206USD | 11,655,377USD | 14,704,294USD | 19,163,772USD | 16,544,462USD | 2,283,249USD |
| Other Current Assets | 1,415,872USD | 1,776,299USD | 1,906,462USD | 1,528,667USD | 1,301,485USD | 1,624,768USD | 1,696,513USD | 243,430USD |
| Total Liabilities | 12,129,372USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 2,831,295USD | 2,560,024USD | 3,059,203USD | 2,596,809USD | 1,885,188USD | 2,579,825USD | 3,176,336USD | 1,333,818USD |
| Other Current Liabilities | 2,352,744USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 68,366,108USD | 80,623,352USD | 74,896,867USD | 77,385,109USD | 82,540,623USD | 7,086,931USD | 64,281,023USD | 949,431USD |
| Total Equity Including Noncontrolling Interest | 68,366,108USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 142,569USD | 159,295USD | 194,931USD | 189,301USD | 207,143USD | 209,658USD | 222,648USD | — |
| Goodwill | 11,961,275USD | — | — | — | — | — | — | — |
| Intangible Assets | 57,347,369USD | 67,831,894USD | 68,985,026USD | 67,919,601USD | 69,303,582USD | 77,593,108USD | 65,710,527USD | — |
| Accounts Payable | 411,516USD | 144,400USD | 760,945USD | 584,602USD | 498,118USD | 1,153,642USD | 1,231,805USD | 454,962USD |
| Short Term Debt | 57,645USD | 57,314USD | 56,841USD | 54,566USD | 54,496USD | 50,719USD | 99,392USD | — |
| Common Stock | 3,363USD | 3,340USD | 2,974USD | 229USD | 191USD | 191USD | 133USD | 111USD |
| Retained Earnings | -124,592,539USD | -113,062,930USD | -108,076,316USD | -104,295,867USD | -88,551,251USD | -84,743,898USD | -73,818,946USD | -66,091,074USD |
| Accumulated Other Comprehensive Income | -2,991,811USD | -1,720,950USD | -587,039USD | -1,636,135USD | -267,289USD | -3,801,831USD | -3,862,987USD | — |
| Total Liab | — | 14,584,519USD | 15,274,370USD | 14,607,504USD | 14,151,904USD | 89,897,757USD | 30,027,223USD | 1,333,818USD |
| Other Current Liab | — | 2,348,737USD | 2,241,417USD | 1,957,641USD | 1,332,574USD | 1,375,464USD | 1,845,139USD | 878,856USD |
| Capital Stock | — | 3,340USD | 2,974USD | 110,457,553USD | 100,656,676USD | 100,656,676USD | 74,405,495USD | 111USD |
| Good Will | — | 12,193,825USD | 12,401,118USD | 12,209,591USD | 12,458,383USD | 11,823,159USD | 11,812,476USD | — |
| Cash | — | 13,227,839USD | 6,524,744USD | 10,126,710USD | 13,402,809USD | 17,539,004USD | 14,847,949USD | 2,039,819USD |
| Cash And Short Term Investments | — | 13,227,839USD | 6,524,744USD | 10,126,710USD | 13,402,809USD | 17,539,004USD | 14,847,949USD | 2,039,819USD |
| Current Deferred Revenue | — | 9,573USD | — | — | — | — | — | — |
| Net Debt | — | -13,082,909USD | -6,362,140USD | -9,951,932USD | -13,215,819USD | 58,314,264USD | 737,709USD | -2,039,819USD |
| Short Long Term Debt Total | — | 144,930USD | 162,604USD | 174,778USD | 186,990USD | 75,853,268USD | 15,585,658USD | — |
| Property Plant Equipment Gross | — | 178,014USD | 194,931USD | 211,756USD | 229,482USD | 230,313USD | 224,224USD | — |
| Common Stock Shares Outstanding | — | 33,544,748shares | 14,521,199shares | 1,919,433shares | 1,441,535shares | 1,441,535shares | 1,310,474shares | 1,110,317shares |
| Non Current Assets Total | — | 80,203,733USD | 81,740,031USD | 80,337,236USD | 81,988,233USD | 77,820,916USD | 77,763,784USD | 0USD |
| Non Current Liabilities Total | — | 12,024,495USD | 12,215,167USD | 12,010,695USD | 12,266,716USD | 87,317,932USD | 26,850,887USD | 0USD |
| Non Currrent Assets Other | — | 18,719USD | 158,956USD | — | — | — | 18,133USD | — |
| Net Working Capital | — | 12,444,114USD | 5,372,003USD | 9,058,568USD | 12,819,106USD | 16,583,947USD | 13,368,126USD | 949,431USD |
| Unclassified Non Current Liabilities | — | 12,024,495USD | 12,215,167USD | 12,010,695USD | 12,266,716USD | 87,317,932USD | 11,469,810USD | — |
| Unclassified Equity | — | 195,400,552USD | 183,554,274USD | 72,859,329USD | 70,702,296USD | -5,024,207USD | 67,557,328USD | 67,040,283USD |
| Unclassified Non Current Assets | — | — | — | — | — | -11,805,009USD | — | — |
| Other Assets | — | — | — | — | — | — | -6,903,739USD | — |
| Long Term Debt | — | — | — | — | — | — | 15,381,077USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 90,171,237USD | 94,308,246USD | 4,165,442USD | 8,369,756USD | 15,776,687USD | 31,472,731USD | 315,900USD | 65,935USD |
| Intangible Assets | 68,985,026USD | 65,710,527USD | — | — | — | — | — | — |
| Other Current Assets | 1,906,462USD | 1,696,513USD | 848,496USD | 1,338,764USD | 1,768,503USD | 1,677,041USD | 5,731USD | 12,038USD |
| Total Liab | 15,274,370USD | 30,027,223USD | 358,548USD | 1,043,262USD | 1,275,623USD | 1,531,842USD | 5,258,409USD | 1,326,333USD |
| Total Stockholder Equity | 74,896,867USD | 64,281,023USD | 3,806,894USD | 7,326,494USD | 14,501,064USD | 29,940,889USD | -4,942,509USD | -1,260,398USD |
| Other Current Liab | 2,241,417USD | 1,845,139USD | 246,635USD | 470,098USD | 921,760USD | 1,162,937USD | 1,585,445USD | 1,180,677USD |
| Common Stock | 2,974USD | 133USD | 77USD | 1,833USD | 833USD | 830USD | 12,601,201USD | 12,601,201USD |
| Capital Stock | 2,974USD | 74,405,495USD | 77USD | 1,833USD | 833USD | 830USD | — | — |
| Retained Earnings | -108,076,316USD | -73,818,946USD | -61,469,222USD | -56,173,207USD | -43,925,373USD | -27,965,105USD | -17,618,710USD | -15,145,083USD |
| Good Will | 12,401,118USD | 11,812,476USD | 0USD | — | — | — | — | — |
| Cash | 6,524,744USD | 14,847,949USD | 3,316,946USD | 7,030,992USD | 14,008,184USD | 29,795,366USD | 309,384USD | 30,026USD |
| Cash And Short Term Investments | 6,524,744USD | 14,847,949USD | 3,316,946USD | 7,030,992USD | 14,008,184USD | 29,795,366USD | 309,384USD | 30,026USD |
| Total Current Assets | 8,431,206USD | 16,544,462USD | 4,165,442USD | 8,369,756USD | 15,776,687USD | 31,472,731USD | 315,900USD | 42,398USD |
| Total Current Liabilities | 3,059,203USD | 3,176,336USD | 358,548USD | 1,043,262USD | 1,275,623USD | 1,531,842USD | 1,620,866USD | 1,326,333USD |
| Net Debt | -6,362,140USD | 737,709USD | -3,316,946USD | -7,030,992USD | -14,008,184USD | -29,795,366USD | 3,328,159USD | -30,026USD |
| Short Term Debt | 56,841USD | 99,392USD | — | — | — | — | — | — |
| Short Long Term Debt Total | 162,604USD | 15,585,658USD | — | — | — | — | 3,637,543USD | — |
| Accounts Payable | 760,945USD | 1,231,805USD | 111,913USD | 573,164USD | 353,863USD | 368,905USD | 35,421USD | 145,656USD |
| Property Plant Equipment Net | 194,931USD | 222,648USD | 0USD | — | — | — | — | — |
| Property Plant Equipment Gross | 194,931USD | 224,224USD | 0USD | — | — | — | — | — |
| Accumulated Other Comprehensive Income | -587,039USD | -3,862,987USD | — | — | — | — | — | — |
| Common Stock Shares Outstanding | 8,220,316shares | 1,027,787shares | 751,071shares | 442,804shares | 333,172shares | 197,079shares | 193,299shares | 193,299shares |
| Non Current Assets Total | 81,740,031USD | 77,763,784USD | 0USD | 0USD | 0USD | 0USD | — | 23,537USD |
| Non Current Liabilities Total | 12,215,167USD | 26,850,887USD | 0USD | 0USD | 0USD | 0USD | 3,637,543USD | — |
| Non Currrent Assets Other | 158,956USD | 18,133USD | — | — | — | — | — | 23,537USD |
| Net Working Capital | 5,372,003USD | 13,368,126USD | 3,806,894USD | 7,326,494USD | 14,501,064USD | 29,940,889USD | — | — |
| Unclassified Non Current Liabilities | 12,215,167USD | 11,469,810USD | — | — | — | — | 3,637,543USD | — |
| Unclassified Equity | 183,554,274USD | 67,557,328USD | 65,275,962USD | 63,496,035USD | 58,424,771USD | 57,904,334USD | — | 1,283,484USD |
| Other Assets | — | -6,903,739USD | — | — | — | — | — | — |
| Long Term Debt | — | 15,381,077USD | — | — | — | — | — | — |
| Net Receivables | — | — | — | — | — | 324USD | 785USD | 334USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 992,622USD |
| Deferred Income Tax | -2,479,501USD |
| Change To Liabilities | -105,226USD |
| Change In Working Capital | 323,342USD |
| Operating Cash Flow | -8,198,274USD |
| Financing Cash Flow | 11,291,348USD |
| Effect Of Forex Changes On Cash | -7,785USD |
| Change In Cash | 3,085,289USD |
| End Cash Flow | 9,610,033USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,986,614USD | -3,780,449USD | -15,744,616USD | -3,807,353USD | -10,924,952USD | -7,727,872USD | -2,280,684USD | -1,049,833USD |
| Depreciation | 16,839USD | 0USD | 17,338USD | 17,256USD | 17,022USD | — | 0USD | 0USD |
| Stock Based Compensation | 449,419USD | 157,860USD | 48,281USD | 65,027USD | 84,474USD | 93,802USD | 94,302USD | 148,948USD |
| Other Non Cash Items | 494,190USD | -90,744USD | 12,094,189USD | -5,174USD | 6,193,379USD | 3,664,669USD | — | — |
| Change In Working Capital | -112,795USD | 44,305USD | 361,733USD | -296,023USD | -243,019USD | -2,161,604USD | 1,276,245USD | 89,139USD |
| Total Cash From Operating Activities | -4,587,187USD | -3,637,187USD | -3,272,792USD | -4,026,118USD | -4,682,554USD | -6,131,508USD | -910,137USD | -811,746USD |
| Capital Expenditures | -3USD | 0USD | -2USD | 0USD | -4USD | 0USD | -3USD | -4USD |
| Free Cash Flow | -4,587,190USD | -3,637,187USD | -3,272,790USD | -4,026,119USD | -4,682,550USD | -6,131,508USD | -910,137USD | -811,746USD |
| Net Borrowings | 0USD | 0USD | 0USD | 0USD | 3,000,000USD | — | 0USD | — |
| Total Cash From Financing Activities | 11,291,325USD | 32,561USD | 0USD | -120,133USD | 7,372,378USD | 15,322,294USD | -70,227USD | 1,452,397USD |
| Issuance Of Capital Stock | 11,397,459USD | 86,366USD | 0USD | -120,133USD | 4,372,378USD | 0USD | -70,227USD | 1,452,397USD |
| Change In Cash | 6,703,095USD | -3,601,966USD | -3,276,099USD | -4,136,195USD | 2,691,055USD | 12,808,130USD | -980,364USD | 640,651USD |
| Begin Period Cash Flow | 6,524,744USD | 10,126,710USD | 13,402,809USD | 17,539,004USD | 14,847,949USD | 2,039,819USD | 3,020,183USD | 2,379,532USD |
| End Period Cash Flow | 13,227,839USD | 6,524,744USD | 10,126,710USD | 13,402,809USD | 17,539,004USD | 14,847,949USD | 2,039,819USD | 3,020,183USD |
| Other Cashflows From Financing Activities | — | -53,805USD | — | -3,000,000USD | 3,000,000USD | -351USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | 3,000,000USD | -3,000,000USD | 15,322,645USD | — | — |
| Total Cashflows From Investing Activities | — | — | — | — | — | 3,761,936USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 3,761,936USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -34,257,370USD | -12,349,724USD | -5,296,015USD | -12,247,834USD | -15,960,268USD | -10,346,395USD | -2,473,627USD | -2,113,592USD |
| Depreciation | 2,063USD | 12,177USD | 0USD | — | — | — | — | — |
| Stock Based Compensation | 355,642USD | 476,021USD | 619,972USD | 582,659USD | 322,881USD | 7,429,518USD | — | — |
| Other Non Cash Items | 18,192,922USD | 3,652,492USD | — | — | — | -4,258USD | 65,000USD | 48,505USD |
| Change In Working Capital | -133,004USD | -581,268USD | -194,446USD | 197,378USD | -52,191USD | -974,060USD | 316,476USD | 869,132USD |
| Total Cash From Operating Activities | -15,618,651USD | -8,790,805USD | -4,870,489USD | -11,467,797USD | -15,689,578USD | -3,895,195USD | -2,092,150USD | -1,195,955USD |
| Capital Expenditures | 0USD | -5USD | 0USD | -3USD | 0USD | -5USD | 0USD | 0USD |
| Free Cash Flow | -15,618,651USD | -8,790,805USD | -4,870,489USD | -11,467,797USD | -15,689,578USD | -3,895,195USD | -2,092,150USD | -1,195,955USD |
| Net Borrowings | 3,000,000USD | 15,322,645USD | 0USD | — | 0USD | — | — | — |
| Total Cash From Financing Activities | 7,284,806USD | 16,704,464USD | 1,156,443USD | 4,490,605USD | -97,604USD | 33,381,177USD | 2,371,508USD | 1,150,468USD |
| Sale Purchase Of Stock | 0USD | -351USD | 0USD | — | -295,166USD | — | — | — |
| Issuance Of Capital Stock | 4,338,611USD | 1,382,170USD | 1,156,443USD | 4,490,605USD | — | 31,349,055USD | — | — |
| Change In Cash | -8,323,205USD | 11,531,003USD | -3,714,046USD | -6,977,192USD | -15,787,182USD | 29,485,982USD | 279,358USD | -45,487USD |
| Begin Period Cash Flow | 14,847,949USD | 3,316,946USD | 7,030,992USD | 14,008,184USD | 29,795,366USD | 309,384USD | 30,026USD | 75,513USD |
| End Period Cash Flow | 6,524,744USD | 14,847,949USD | 3,316,946USD | 7,030,992USD | 14,008,184USD | 29,795,366USD | 309,384USD | 30,026USD |
| Other Cashflows From Financing Activities | -53,805USD | -351USD | — | — | 197,562USD | 112,989USD | -58,492USD | 1,150,468USD |
| Unclassified Financing Cash Flow | 4,338,611USD | 1,382,521USD | 1,156,443USD | — | — | 1,994,133USD | 2,430,000USD | — |
| Investments | — | 3,761,936USD | 0USD | — | — | — | — | — |
| Total Cashflows From Investing Activities | — | 3,761,936USD | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | 0USD | -75,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.